DEXCOM, INC. (DXCM) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
72/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
LoseDXCM / S&P 7.25% / 15.20% |
WinDXCM / S&P 15.54% / 15.00% |
WinDXCM / S&P 75.00% / 50.40% |
| 2026-Q12/3 |
LoseDXCM / S&P -5.38% / -4.33% |
WinDXCM / S&P 16.15% / 11.30% |
WinDXCM / S&P 73.88% / 27.70% |
| 2025-Q42/3 |
LoseDXCM / S&P -1.37% / 2.65% |
WinDXCM / S&P 15.60% / 9.00% |
WinDXCM / S&P 46.15% / 13.40% |
| 2025-Q31/3 |
LoseDXCM / S&P -22.91% / 8.12% |
WinDXCM / S&P 14.21% / 4.61% |
LoseDXCM / S&P 8.43% / 13.45% |
| 2025-Q22/3 |
WinDXCM / S&P 27.82% / 10.94% |
WinDXCM / S&P 9.30% / 4.83% |
LoseDXCM / S&P -10.56% / 10.63% |
| 2025-Q11/3 |
LoseDXCM / S&P -12.19% / -4.27% |
WinDXCM / S&P 9.11% / 4.98% |
LoseDXCM / S&P -12.99% / 10.57% |
| 2024-Q43/3 |
WinDXCM / S&P 16.01% / 2.41% |
WinDXCM / S&P 11.34% / 5.25% |
WinDXCM / S&P 10.00% / 6.15% |
| 2024-Q32/3 |
LoseDXCM / S&P -40.87% / 5.89% |
WinDXCM / S&P 16.19% / 5.89% |
WinDXCM / S&P 82.42% / 6.11% |
| 2024-Q22/3 |
LoseDXCM / S&P -18.26% / 4.28% |
WinDXCM / S&P 23.05% / 5.38% |
WinDXCM / S&P 87.21% / 5.12% |
| 2024-Q13/3 |
WinDXCM / S&P 11.77% / 10.56% |
WinDXCM / S&P 25.78% / 5.71% |
WinDXCM / S&P 120.00% / 5.59% |
| 2023-Q43/3 |
WinDXCM / S&P 33.00% / 11.69% |
WinDXCM / S&P 24.49% / 6.81% |
WinDXCM / S&P 60.49% / 7.78% |
| 2023-Q32/3 |
LoseDXCM / S&P -27.40% / -3.27% |
WinDXCM / S&P 21.85% / 7.52% |
WinDXCM / S&P 56.90% / -5.03% |
| 2023-Q23/3 |
WinDXCM / S&P 10.61% / 8.74% |
WinDXCM / S&P 19.61% / 9.50% |
WinDXCM / S&P 56.36% / -8.57% |
| 2023-Q12/3 |
LoseDXCM / S&P 2.60% / 7.50% |
WinDXCM / S&P 17.50% / 10.77% |
WinDXCM / S&P 12.90% / -15.69% |
| 2022-Q43/3 |
WinDXCM / S&P 40.60% / 7.56% |
WinDXCM / S&P 18.84% / 11.88% |
WinDXCM / S&P -14.74% / -17.99% |
| 2022-Q32/3 |
WinDXCM / S&P 8.06% / -4.88% |
WinDXCM / S&P 20.42% / 13.47% |
LoseDXCM / S&P -32.56% / -1.41% |
| 2022-Q21/3 |
LoseDXCM / S&P -41.73% / -16.10% |
WinDXCM / S&P 23.20% / 13.71% |
LoseDXCM / S&P -60.14% / 11.04% |
| 2022-Q11/3 |
LoseDXCM / S&P -4.72% / -4.60% |
WinDXCM / S&P 26.93% / 15.97% |
LoseDXCM / S&P -62.87% / 42.23% |
| 2021-Q41/3 |
LoseDXCM / S&P -1.81% / 11.03% |
WinDXCM / S&P 27.08% / 15.00% |
LoseDXCM / S&P -28.03% / 96.40% |
| 2021-Q32/3 |
WinDXCM / S&P 28.07% / 0.58% |
WinDXCM / S&P 27.39% / 10.77% |
LoseDXCM / S&P -64.61% / 69.42% |
| 2021-Q22/3 |
WinDXCM / S&P 18.81% / 8.55% |
WinDXCM / S&P 26.45% / 6.58% |
LoseDXCM / S&P -37.27% / 51.81% |
| 2021-Q11/3 |
LoseDXCM / S&P -2.79% / 6.17% |
WinDXCM / S&P 26.62% / -1.06% |
LoseDXCM / S&P 4.37% / 7.39% |
| 2020-Q42/3 |
LoseDXCM / S&P -10.31% / 12.15% |
WinDXCM / S&P 30.54% / -3.72% |
WinDXCM / S&P 21.10% / -33.42% |
| 2020-Q31/3 |
LoseDXCM / S&P 1.68% / 8.93% |
WinDXCM / S&P 34.74% / -2.04% |
LoseDXCM / S&P -224.62% / -27.10% |
| 2020-Q22/3 |
WinDXCM / S&P 50.56% / 20.54% |
WinDXCM / S&P 40.47% / -0.46% |
LoseDXCM / S&P -213.99% / -27.11% |
| 2020-Q12/3 |
WinDXCM / S&P 23.10% / -19.60% |
WinDXCM / S&P 41.93% / 3.47% |
LoseDXCM / S&P -208.84% / -14.75% |
| 2019-Q42/3 |
WinDXCM / S&P 46.57% / 9.07% |
WinDXCM / S&P 43.08% / 5.36% |
LoseDXCM / S&P DXCM unavailable / 2.99% |
| 2019-Q31/3 |
LoseDXCM / S&P -0.40% / 1.70% |
WinDXCM / S&P 47.74% / 5.02% |
LoseDXCM / S&P DXCM unavailable / 0.21% |
| 2019-Q22/3 |
WinDXCM / S&P 25.81% / 4.30% |
WinDXCM / S&P 46.74% / 6.64% |
LoseDXCM / S&P DXCM unavailable / 8.65% |
| 2019-Q11/3 |
LoseDXCM / S&P -0.58% / 13.65% |
WinDXCM / S&P 48.26% / 8.12% |
LoseDXCM / S&P DXCM unavailable / 14.29% |
| 2018-Q41/3 |
LoseDXCM / S&P -16.25% / -13.52% |
WinDXCM / S&P 43.58% / 9.05% |
LoseDXCM / S&P DXCM unavailable / 18.23% |
| 2018-Q32/3 |
WinDXCM / S&P 50.60% / 7.71% |
WinDXCM / S&P 36.77% / 10.21% |
LoseDXCM / S&P DXCM unavailable / 19.06% |
| 2018-Q22/3 |
WinDXCM / S&P 28.07% / 3.43% |
WinDXCM / S&P 31.58% / 9.03% |
LoseDXCM / S&P DXCM unavailable / 14.46% |
| 2018-Q12/3 |
WinDXCM / S&P 29.22% / -0.76% |
WinDXCM / S&P 26.89% / 7.68% |
LoseDXCM / S&P DXCM unavailable / 12.46% |
| 2017-Q42/3 |
WinDXCM / S&P 17.29% / 6.64% |
WinDXCM / S&P 25.33% / 7.03% |
LoseDXCM / S&P DXCM unavailable / 13.82% |
| 2017-Q31/3 |
LoseDXCM / S&P -33.11% / 4.48% |
WinDXCM / S&P 25.48% / 5.68% |
LoseDXCM / S&P DXCM unavailable / 17.57% |
| 2017-Q21/3 |
LoseDXCM / S&P -13.67% / 3.09% |
WinDXCM / S&P 29.25% / 4.83% |
LoseDXCM / S&P DXCM unavailable / 17.74% |
| 2017-Q12/3 |
WinDXCM / S&P 41.93% / 6.07% |
WinDXCM / S&P 34.58% / 3.67% |
LoseDXCM / S&P DXCM unavailable / 13.32% |
| 2016-Q41/3 |
LoseDXCM / S&P -31.90% / 3.82% |
WinDXCM / S&P 42.61% / 2.09% |
LoseDXCM / S&P DXCM unavailable / 7.05% |
| 2016-Q32/3 |
WinDXCM / S&P 10.50% / 3.85% |
WinDXCM / S&P 49.90% / 0.20% |
LoseDXCM / S&P DXCM unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | DXCM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 18.52% | 20.78% |
| Annualized return | 18.52% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | DXCM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -34.46% | 83.14% |
| Annualized return | -8.10% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | DXCM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 289.44% | 319.30% |
| Annualized return | 14.56% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |